Amifostine-induced Stevens-Johnson syndrome during radiotherapy;Syndrome de Stevens-Johnson à l'amifostine en cours de radiothérapie

Annales de Dermatologie et de Venereologie

Volumn 135, Issue 4, 2008, Pages 315-317

  Duparc, A ^a   Delaporte, E ^a   Coche, B ^b   Piette, F ^a   Mortier, L ^a  

^a UNIV LILLE   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; RADIOPROTECTIVE AGENT;

ADULT; BULLOUS SKIN DISEASE; CANCER RADIOTHERAPY; CASE REPORT; ERYTHEMA; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LETTER; LYMPHOCYTOSIS; METASTASIS; RADIATION DOSE; RADIATION INJURY; SKIN ULCER; STEVENS JOHNSON SYNDROME; UNDIFFERENTIATED CARCINOMA; CHEMICALLY INDUCED DISORDER; RADIOTHERAPY;

ADULT; AMIFOSTINE; FEMALE; HUMANS; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; STEVENS-JOHNSON SYNDROME;

EID: 50349097544     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2007.08.003     Document Type: Letter

References (10)

1. Brizel D.M., Wasserman T.H., Henke M., Strnad V., Rudat V., Monnier A., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
2. Lale Atahan I., Ozyar E., Sahin S., Yildiz F., Yalcin B., and Karaduman A. Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy. Br J Dermatol 143 (2000) 1072-1073
3. Astudillo L., Maachi B., Benyoucef A., Game X., Rives M., and Bachaud J.M. Stevens-Johnson syndrome after amifostine during radiotherapy. Int J Dermatol 43 (2004) 284-285
4. Demiral A.N., Yerebakan O., Simsir V., and Alpsoy E. Amifostine-Induced toxic epidermal necrolysis during radiotherapy: a case report. Jpn J Clin Oncol 32 (2002) 477-479
5. Rades D., Fehlauer F., Bajrovic A., Mahlmann B., Richter E., and Alberti W. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol 70 (2004) 261-264
6. Boccia R., Anne P.R., Bourhis J., Brizel D., Daly C., Holloway III N., et al. Assessment and management of cutaneous reactions with amifostine administration: findings of the Ethyol (Amifostine) Cutaneous Treatment Advisory Panel (ECTAP). Int J Radiat Oncol Biol Phys 60 (2004) 302-309
7. Valeyrie Allanore L., Poulhalon N., Fagot J., Hellmer A., Davidovici B., Sidoroff A., et al. Amifostine, une nouvelle molécule à haut risque de syndrome de Stevens-Johnson et nécrolyse toxique épidermique. Ann Dermatol Venereol 133 (2006) 4S261
8. Khafaga Y.M., Jamshed A., Allam A.A., Mourad W.A., Ezzat A., Al Eisa A., et al. Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncol 38 (1999) 111-116
9. Ahmed I., Reichenberg J., Lucas A., and Shehan J.M. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol 43 (2004) 67-73
10. Bégaud B., Evreux J.C., Jouglard J., and Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 40 (1985) 111-118